ID   SYFA_HUMAN              Reviewed;         508 AA.
AC   Q9Y285; B4E363; Q9NSD8; Q9Y4W8;
DT   08-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 171.
DE   RecName: Full=Phenylalanine--tRNA ligase alpha subunit;
DE            EC=6.1.1.20 {ECO:0000269|PubMed:20223217};
DE   AltName: Full=CML33;
DE   AltName: Full=Phenylalanyl-tRNA synthetase alpha subunit;
DE            Short=PheRS;
GN   Name=FARSA; Synonyms=FARS, FARSL, FARSLA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9177188; DOI=10.1073/pnas.94.12.6164;
RA   Sen S., Zhou H., Ripmaster T., Hittelman W.N., Schimmel P.,
RA   White R.A.;
RT   "Expression of a gene encoding a tRNA synthetase-like protein is
RT   enhanced in tumorigenic human myeloid leukemia cells and is cell cycle
RT   stage- and differentiation-dependent.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:6164-6169(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10049785; DOI=10.1006/bbrc.1999.0141;
RA   Rodova M., Ankilova V., Safro M.G.;
RT   "Human phenylalanyl-tRNA synthetase: cloning, characterization of the
RT   deduced amino acid sequences in terms of the structural domains and
RT   coordinately regulated expression of the alpha and beta subunits in
RT   chronic myeloid leukemia cells.";
RL   Biochem. Biophys. Res. Commun. 255:765-773(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Motegi H., Noda T., Shiba K.;
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Leukocyte, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-12.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-12 AND 326-334, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (OCT-2004) to UniProtKB.
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-311, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-190, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18] {ECO:0000244|PDB:3L4G}
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) IN COMPLEX WITH
RP   L-PHENYLALANINE, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=20223217; DOI=10.1016/j.str.2010.01.002;
RA   Finarov I., Moor N., Kessler N., Klipcan L., Safro M.G.;
RT   "Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence
RT   for kingdom-specific design of the active sites and tRNA binding
RT   patterns.";
RL   Structure 18:343-353(2010).
CC   -!- CATALYTIC ACTIVITY: ATP + L-phenylalanine + tRNA(Phe) = AMP +
CC       diphosphate + L-phenylalanyl-tRNA(Phe).
CC       {ECO:0000269|PubMed:20223217}.
CC   -!- SUBUNIT: Heterotetramer; dimer of two heterodimers formed by FARSA
CC       and FARSB. {ECO:0000269|PubMed:20223217}.
CC   -!- INTERACTION:
CC       Q9P2A4:ABI3; NbExp=3; IntAct=EBI-725361, EBI-742038;
CC       Q9BQ95:ECSIT; NbExp=2; IntAct=EBI-725361, EBI-712452;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q505J8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y285-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y285-2; Sequence=VSP_056196;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. Phe-tRNA synthetase alpha subunit type 2 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB51175.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07424; AAB61694.1; -; mRNA.
DR   EMBL; AF042347; AAD02221.1; -; mRNA.
DR   EMBL; D84471; BAA95666.1; -; mRNA.
DR   EMBL; BT007198; AAP35862.1; -; mRNA.
DR   EMBL; AK304587; BAG65375.1; -; mRNA.
DR   EMBL; AD000092; AAB51175.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC006495; AAH06495.1; -; mRNA.
DR   EMBL; BC043565; AAH43565.1; -; mRNA.
DR   CCDS; CCDS12287.1; -. [Q9Y285-1]
DR   PIR; T45074; T45074.
DR   RefSeq; NP_004452.1; NM_004461.2. [Q9Y285-1]
DR   UniGene; Hs.23111; -.
DR   PDB; 3L4G; X-ray; 3.30 A; A/C/E/G/I/K/M/O=1-508.
DR   PDBsum; 3L4G; -.
DR   ProteinModelPortal; Q9Y285; -.
DR   SMR; Q9Y285; -.
DR   BioGrid; 108487; 39.
DR   DIP; DIP-53610N; -.
DR   IntAct; Q9Y285; 26.
DR   MINT; MINT-1378519; -.
DR   STRING; 9606.ENSP00000320309; -.
DR   DrugBank; DB00120; L-Phenylalanine.
DR   iPTMnet; Q9Y285; -.
DR   PhosphoSitePlus; Q9Y285; -.
DR   BioMuta; FARSA; -.
DR   DMDM; 12643946; -.
DR   EPD; Q9Y285; -.
DR   PaxDb; Q9Y285; -.
DR   PeptideAtlas; Q9Y285; -.
DR   PRIDE; Q9Y285; -.
DR   DNASU; 2193; -.
DR   Ensembl; ENST00000314606; ENSP00000320309; ENSG00000179115. [Q9Y285-1]
DR   Ensembl; ENST00000423140; ENSP00000396548; ENSG00000179115. [Q9Y285-2]
DR   GeneID; 2193; -.
DR   KEGG; hsa:2193; -.
DR   UCSC; uc002mvs.3; human. [Q9Y285-1]
DR   CTD; 2193; -.
DR   DisGeNET; 2193; -.
DR   GeneCards; FARSA; -.
DR   HGNC; HGNC:3592; FARSA.
DR   HPA; HPA001911; -.
DR   MIM; 602918; gene.
DR   neXtProt; NX_Q9Y285; -.
DR   OpenTargets; ENSG00000179115; -.
DR   PharmGKB; PA28005; -.
DR   eggNOG; KOG2784; Eukaryota.
DR   eggNOG; COG0016; LUCA.
DR   GeneTree; ENSGT00390000006387; -.
DR   HOGENOM; HOG000230294; -.
DR   HOVERGEN; HBG068046; -.
DR   InParanoid; Q9Y285; -.
DR   KO; K01889; -.
DR   PhylomeDB; Q9Y285; -.
DR   TreeFam; TF300647; -.
DR   BRENDA; 6.1.1.20; 2681.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   GeneWiki; FARSA_(gene); -.
DR   GenomeRNAi; 2193; -.
DR   PRO; PR:Q9Y285; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000179115; -.
DR   CleanEx; HS_FARSA; -.
DR   ExpressionAtlas; Q9Y285; baseline and differential.
DR   Genevisible; Q9Y285; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0009328; C:phenylalanine-tRNA ligase complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004826; F:phenylalanine-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; IEA:InterPro.
DR   GO; GO:0006432; P:phenylalanyl-tRNA aminoacylation; IDA:UniProtKB.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004529; Phe-tRNA-synth_IIc_asu.
DR   InterPro; IPR002319; Phenylalanyl-tRNA_Synthase.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   Pfam; PF01409; tRNA-synt_2d; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   TIGRFAMs; TIGR00468; pheS; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Ligase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.9}.
FT   CHAIN         2    508       Phenylalanine--tRNA ligase alpha subunit.
FT                                /FTId=PRO_0000126824.
FT   REGION      372    374       L-phenylalanine binding.
FT                                {ECO:0000244|PDB:3L4G,
FT                                ECO:0000269|PubMed:20223217}.
FT   BINDING     329    329       L-phenylalanine. {ECO:0000244|PDB:3L4G,
FT                                ECO:0000269|PubMed:20223217}.
FT   BINDING     435    435       L-phenylalanine. {ECO:0000244|PDB:3L4G,
FT                                ECO:0000269|PubMed:20223217}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.9}.
FT   MOD_RES     190    190       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     193    193       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C0C7}.
FT   MOD_RES     311    311       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     169    199       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056196.
FT   VARIANT     341    341       Q -> R (in dbSNP:rs35087277).
FT                                /FTId=VAR_052641.
FT   CONFLICT    179    179       S -> G (in Ref. 3; BAA95666).
FT                                {ECO:0000305}.
FT   CONFLICT    376    376       V -> L (in Ref. 3; BAA95666).
FT                                {ECO:0000305}.
FT   HELIX         4     16       {ECO:0000244|PDB:3L4G}.
FT   STRAND       17     19       {ECO:0000244|PDB:3L4G}.
FT   HELIX        25     28       {ECO:0000244|PDB:3L4G}.
FT   TURN         29     31       {ECO:0000244|PDB:3L4G}.
FT   HELIX        37     41       {ECO:0000244|PDB:3L4G}.
FT   HELIX        43     46       {ECO:0000244|PDB:3L4G}.
FT   STRAND       53     61       {ECO:0000244|PDB:3L4G}.
FT   HELIX        65     73       {ECO:0000244|PDB:3L4G}.
FT   HELIX        76     83       {ECO:0000244|PDB:3L4G}.
FT   HELIX        91     94       {ECO:0000244|PDB:3L4G}.
FT   HELIX        98    108       {ECO:0000244|PDB:3L4G}.
FT   TURN        109    111       {ECO:0000244|PDB:3L4G}.
FT   STRAND      112    114       {ECO:0000244|PDB:3L4G}.
FT   STRAND      119    121       {ECO:0000244|PDB:3L4G}.
FT   STRAND      126    128       {ECO:0000244|PDB:3L4G}.
FT   HELIX       135    143       {ECO:0000244|PDB:3L4G}.
FT   TURN        144    149       {ECO:0000244|PDB:3L4G}.
FT   HELIX       153    161       {ECO:0000244|PDB:3L4G}.
FT   STRAND      167    175       {ECO:0000244|PDB:3L4G}.
FT   TURN        194    198       {ECO:0000244|PDB:3L4G}.
FT   TURN        201    204       {ECO:0000244|PDB:3L4G}.
FT   STRAND      212    214       {ECO:0000244|PDB:3L4G}.
FT   HELIX       226    240       {ECO:0000244|PDB:3L4G}.
FT   STRAND      251    254       {ECO:0000244|PDB:3L4G}.
FT   HELIX       255    258       {ECO:0000244|PDB:3L4G}.
FT   HELIX       260    262       {ECO:0000244|PDB:3L4G}.
FT   STRAND      266    268       {ECO:0000244|PDB:3L4G}.
FT   TURN        273    275       {ECO:0000244|PDB:3L4G}.
FT   STRAND      278    280       {ECO:0000244|PDB:3L4G}.
FT   HELIX       290    301       {ECO:0000244|PDB:3L4G}.
FT   HELIX       316    319       {ECO:0000244|PDB:3L4G}.
FT   STRAND      321    324       {ECO:0000244|PDB:3L4G}.
FT   HELIX       329    340       {ECO:0000244|PDB:3L4G}.
FT   STRAND      342    344       {ECO:0000244|PDB:3L4G}.
FT   STRAND      348    357       {ECO:0000244|PDB:3L4G}.
FT   STRAND      364    366       {ECO:0000244|PDB:3L4G}.
FT   STRAND      368    381       {ECO:0000244|PDB:3L4G}.
FT   HELIX       384    396       {ECO:0000244|PDB:3L4G}.
FT   TURN        397    399       {ECO:0000244|PDB:3L4G}.
FT   STRAND      404    407       {ECO:0000244|PDB:3L4G}.
FT   STRAND      414    421       {ECO:0000244|PDB:3L4G}.
FT   STRAND      430    436       {ECO:0000244|PDB:3L4G}.
FT   HELIX       440    443       {ECO:0000244|PDB:3L4G}.
FT   HELIX       444    446       {ECO:0000244|PDB:3L4G}.
FT   STRAND      452    461       {ECO:0000244|PDB:3L4G}.
FT   HELIX       462    465       {ECO:0000244|PDB:3L4G}.
FT   TURN        466    470       {ECO:0000244|PDB:3L4G}.
FT   HELIX       474    476       {ECO:0000244|PDB:3L4G}.
FT   HELIX       484    489       {ECO:0000244|PDB:3L4G}.
FT   TURN        497    499       {ECO:0000244|PDB:3L4G}.
SQ   SEQUENCE   508 AA;  57564 MW;  99BC12E1F3C5FCFD CRC64;
     MADGQVAELL LRRLEASDGG LDSAELAAEL GMEHQAVVGA VKSLQALGEV IEAELRSTKH
     WELTAEGEEI AREGSHEARV FRSIPPEGLA QSELMRLPSG KVGFSKAMSN KWIRVDKSAA
     DGPRVFRVVD SMEDEVQRRL QLVRGGQAEK LGEKERSELR KRKLLAEVTL KTYWVSKGSA
     FSTSISKQET ELSPEMISSG SWRDRPFKPY NFLAHGVLPD SGHLHPLLKV RSQFRQIFLE
     MGFTEMPTDN FIESSFWNFD ALFQPQQHPA RDQHDTFFLR DPAEALQLPM DYVQRVKRTH
     SQGGYGSQGY KYNWKLDEAR KNLLRTHTTS ASARALYRLA QKKPFTPVKY FSIDRVFRNE
     TLDATHLAEF HQIEGVVADH GLTLGHLMGV LREFFTKLGI TQLRFKPAYN PYTEPSMEVF
     SYHQGLKKWV EVGNSGVFRP EMLLPMGLPE NVSVIAWGLS LERPTMIKYG INNIRELVGH
     KVNLQMVYDS PLCRLDAEPR PPPTQEAA
//
